Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.
Albrecht-Schgoer K, Schgoer W, Holfeld J, Theurl M, Wiedemann D, Steger C, Gupta R, Semsroth S, Fischer-Colbrie R, Beer AG, Stanzl U, Huber E, Misener S, Dejaco D, Kishore R, Pachinger O, Grimm M, Bonaros N, Kirchmair R. Albrecht-Schgoer K, et al. Circulation. 2012 Nov 20;126(21):2491-501. doi: 10.1161/CIRCULATIONAHA.111.076950. Epub 2012 Oct 18. Circulation. 2012. PMID: 23081990 Free PMC article.
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
Theurl M, Schgoer W, Albrecht-Schgoer K, Lener D, Wolf D, Wolf M, Demetz E, Tymoszuk P, Tancevski I, Fischer-Colbrie R, Franz WM, Marschang P, Kirchmair R. Theurl M, et al. Among authors: albrecht schgoer k. Cardiovasc Res. 2015 Jan 1;105(1):96-106. doi: 10.1093/cvr/cvu237. Epub 2014 Nov 5. Cardiovasc Res. 2015. PMID: 25377726
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
Tepeköylü C, Wang FS, Kozaryn R, Albrecht-Schgoer K, Theurl M, Schaden W, Ke HJ, Yang Y, Kirchmair R, Grimm M, Wang CJ, Holfeld J. Tepeköylü C, et al. J Thorac Cardiovasc Surg. 2013 Oct;146(4):971-8. doi: 10.1016/j.jtcvs.2013.01.017. Epub 2013 Feb 8. J Thorac Cardiovasc Surg. 2013. PMID: 23395097 Free article.
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.
Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr WR, Rix U, Sadovnik I, Jilma B, Schernthaner GH, Wojta J, Wolf D, Superti-Furga G, Kirchmair R, Valent P. Hadzijusufovic E, et al. Among authors: albrecht schgoer k. Leukemia. 2017 Nov;31(11):2388-2397. doi: 10.1038/leu.2017.245. Epub 2017 Jul 31. Leukemia. 2017. PMID: 28757617 Free PMC article.
Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease.
Holfeld J, Zimpfer D, Albrecht-Schgoer K, Stojadinovic A, Paulus P, Dumfarth J, Thomas A, Lobenwein D, Tepeköylü C, Rosenhek R, Schaden W, Kirchmair R, Aharinejad S, Grimm M. Holfeld J, et al. Among authors: albrecht schgoer k. J Tissue Eng Regen Med. 2016 Dec;10(12):1057-1064. doi: 10.1002/term.1890. Epub 2014 May 19. J Tissue Eng Regen Med. 2016. PMID: 24841341
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.
Holfeld J, Tepeköylü C, Reissig C, Lobenwein D, Scheller B, Kirchmair E, Kozaryn R, Albrecht-Schgoer K, Krapf C, Zins K, Urbschat A, Zacharowski K, Grimm M, Kirchmair R, Paulus P. Holfeld J, et al. Among authors: albrecht schgoer k. Cardiovasc Res. 2016 Feb 1;109(2):331-43. doi: 10.1093/cvr/cvv272. Epub 2015 Dec 16. Cardiovasc Res. 2016. PMID: 26676850
14 results